Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × HER2 Positive Breast Carcinoma × Breast × Clear all
NCT06708910 2025-09-24

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Heinrich-Heine University, Duesseldorf

Recruiting
460 enrolled
Breast

HER2 Positive Breast Carcinoma

NCT06868758 2025-03-11

Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

Chongqing General Hospital

Active not recruiting
50 enrolled
Breast

HER2 Positive Breast Carcinoma

NCT03908749 2019-04-09

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

Anhui Provincial Hospital

Unknown
300 enrolled
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡